| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cadmium ion binding | 3.40e-14 | 12 | 39 | 6 | GO:0046870 | |
| GeneOntologyMolecularFunction | copper ion binding | 1.47e-10 | 78 | 39 | 7 | GO:0005507 | |
| GeneOntologyMolecularFunction | L-serine transmembrane transporter activity | 1.33e-04 | 9 | 39 | 2 | GO:0015194 | |
| GeneOntologyMolecularFunction | zinc ion binding | 2.73e-04 | 891 | 39 | 8 | GO:0008270 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 1.81e-03 | 1189 | 39 | 8 | GO:0046914 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 3.19e-03 | 43 | 39 | 2 | GO:0030280 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 8.48e-03 | 71 | 39 | 2 | GO:0015179 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.14e-02 | 83 | 39 | 2 | GO:0015101 | |
| GeneOntologyBiologicalProcess | detoxification of copper ion | 1.71e-22 | 16 | 32 | 9 | GO:0010273 | |
| GeneOntologyBiologicalProcess | stress response to copper ion | 1.71e-22 | 16 | 32 | 9 | GO:1990169 | |
| GeneOntologyBiologicalProcess | stress response to metal ion | 7.41e-21 | 22 | 32 | 9 | GO:0097501 | |
| GeneOntologyBiologicalProcess | detoxification of inorganic compound | 3.03e-20 | 25 | 32 | 9 | GO:0061687 | |
| GeneOntologyBiologicalProcess | cellular response to copper ion | 6.95e-20 | 27 | 32 | 9 | GO:0071280 | |
| GeneOntologyBiologicalProcess | cellular response to chromate | 8.54e-20 | 8 | 32 | 7 | GO:0071247 | |
| GeneOntologyBiologicalProcess | cellular response to zinc ion | 1.02e-19 | 28 | 32 | 9 | GO:0071294 | |
| GeneOntologyBiologicalProcess | response to chromate | 3.84e-19 | 9 | 32 | 7 | GO:0046687 | |
| GeneOntologyBiologicalProcess | cellular response to cadmium ion | 8.22e-18 | 43 | 32 | 9 | GO:0071276 | |
| GeneOntologyBiologicalProcess | response to copper ion | 8.22e-18 | 43 | 32 | 9 | GO:0046688 | |
| GeneOntologyBiologicalProcess | intracellular zinc ion homeostasis | 1.03e-17 | 44 | 32 | 9 | GO:0006882 | |
| GeneOntologyBiologicalProcess | response to zinc ion | 2.48e-16 | 61 | 32 | 9 | GO:0010043 | |
| GeneOntologyBiologicalProcess | response to cadmium ion | 7.01e-16 | 68 | 32 | 9 | GO:0046686 | |
| GeneOntologyBiologicalProcess | nitric oxide mediated signal transduction | 9.64e-16 | 40 | 32 | 8 | GO:0007263 | |
| GeneOntologyBiologicalProcess | detoxification | 3.38e-12 | 170 | 32 | 9 | GO:0098754 | |
| GeneOntologyBiologicalProcess | cellular response to metal ion | 3.30e-11 | 219 | 32 | 9 | GO:0071248 | |
| GeneOntologyBiologicalProcess | response to toxic substance | 3.89e-10 | 289 | 32 | 9 | GO:0009636 | |
| GeneOntologyBiologicalProcess | negative regulation of growth | 8.99e-09 | 283 | 32 | 8 | GO:0045926 | |
| GeneOntologyBiologicalProcess | response to metal ion | 9.23e-09 | 415 | 32 | 9 | GO:0010038 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron apoptotic process | 6.20e-08 | 236 | 32 | 7 | GO:0043524 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 2.53e-07 | 611 | 32 | 9 | GO:0030003 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 2.93e-07 | 622 | 32 | 9 | GO:0006873 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 2.93e-07 | 622 | 32 | 9 | GO:0098771 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 8.38e-07 | 705 | 32 | 9 | GO:0055080 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 9.64e-07 | 717 | 32 | 9 | GO:0050801 | |
| GeneOntologyBiologicalProcess | regulation of neuron apoptotic process | 9.80e-07 | 355 | 32 | 7 | GO:0043523 | |
| GeneOntologyBiologicalProcess | neuron apoptotic process | 2.68e-06 | 413 | 32 | 7 | GO:0051402 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | 4.56e-06 | 866 | 32 | 9 | GO:0055082 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | 1.25e-05 | 981 | 32 | 9 | GO:0019725 | |
| GeneOntologyBiologicalProcess | regulation of growth | 1.84e-05 | 777 | 32 | 8 | GO:0040008 | |
| GeneOntologyBiologicalProcess | L-serine biosynthetic process | 3.48e-05 | 6 | 32 | 2 | GO:0006564 | |
| GeneOntologyBiologicalProcess | detection of virus | 4.87e-05 | 7 | 32 | 2 | GO:0009597 | |
| GeneOntologyBiologicalProcess | L-serine transport | 8.34e-05 | 9 | 32 | 2 | GO:0015825 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | 8.38e-05 | 1249 | 32 | 9 | GO:0048878 | |
| GeneOntologyBiologicalProcess | serine transport | 1.27e-04 | 11 | 32 | 2 | GO:0032329 | |
| GeneOntologyBiologicalProcess | L-serine metabolic process | 1.80e-04 | 13 | 32 | 2 | GO:0006563 | |
| GeneOntologyBiologicalProcess | growth | 4.67e-04 | 1235 | 32 | 8 | GO:0040007 | |
| GeneOntologyBiologicalProcess | serine family amino acid biosynthetic process | 6.84e-04 | 25 | 32 | 2 | GO:0009070 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | 1.49e-03 | 1133 | 32 | 7 | GO:0043066 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | 1.80e-03 | 1171 | 32 | 7 | GO:0043069 | |
| GeneOntologyBiologicalProcess | serine family amino acid metabolic process | 2.02e-03 | 43 | 32 | 2 | GO:0009069 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 3.90e-03 | 60 | 32 | 2 | GO:0015804 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid biosynthetic process | 5.13e-03 | 69 | 32 | 2 | GO:0170038 | |
| GeneOntologyBiologicalProcess | L-amino acid biosynthetic process | 5.27e-03 | 70 | 32 | 2 | GO:0170034 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | 5.93e-03 | 1450 | 32 | 7 | GO:1901701 | |
| GeneOntologyBiologicalProcess | alpha-amino acid biosynthetic process | 6.35e-03 | 77 | 32 | 2 | GO:1901607 | |
| GeneOntologyBiologicalProcess | amino acid biosynthetic process | 7.86e-03 | 86 | 32 | 2 | GO:0008652 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 1.22e-02 | 108 | 32 | 2 | GO:0015807 | |
| GeneOntologyCellularComponent | intermediate filament | KRTAP9-7 KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-10 KRTAP2-1 KRTAP5-6 KRTAP5-2 KRTAP9-6 SCYGR3 KRTAP5-8 SCYGR1 SCYGR2 KRTAP4-16 KRTAP5-5 SCYGR5 KRTAP2-4 KRTAP1-4 KRTAP5-7 KRTAP9-1 KRTAP5-11 KRTAP1-5 SCYGR9 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 1.40e-48 | 227 | 46 | 30 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRTAP9-7 KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-10 KRTAP2-1 KRTAP5-6 KRTAP5-2 KRTAP9-6 SCYGR3 KRTAP5-8 SCYGR1 SCYGR2 KRTAP4-16 KRTAP5-5 SCYGR5 KRTAP2-4 KRTAP1-4 KRTAP5-7 KRTAP9-1 KRTAP5-11 KRTAP1-5 SCYGR9 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 1.50e-46 | 263 | 46 | 30 | GO:0045111 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRTAP9-7 KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-10 KRTAP2-1 KRTAP5-6 KRTAP5-2 KRTAP9-6 SCYGR3 KRTAP5-8 SCYGR1 SCYGR2 KRTAP4-16 KRTAP5-5 SCYGR5 KRTAP2-4 KRTAP1-4 KRTAP5-7 KRTAP9-1 KRTAP5-11 KRTAP1-5 SCYGR9 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 3.26e-30 | 899 | 46 | 30 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | KRTAP9-7 KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-10 KRTAP2-1 KRTAP5-6 KRTAP5-2 KRTAP9-6 SCYGR3 KRTAP5-8 SCYGR1 SCYGR2 KRTAP4-16 KRTAP5-5 SCYGR5 KRTAP2-4 KRTAP1-4 KRTAP5-7 KRTAP9-1 KRTAP5-11 KRTAP1-5 SCYGR9 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 1.00e-26 | 1179 | 46 | 30 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRTAP9-7 KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-10 KRTAP2-1 KRTAP5-6 KRTAP5-2 KRTAP9-6 SCYGR3 KRTAP5-8 SCYGR1 SCYGR2 KRTAP4-16 KRTAP5-5 SCYGR5 KRTAP2-4 KRTAP1-4 KRTAP5-7 KRTAP9-1 KRTAP5-11 KRTAP1-5 SCYGR9 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 1.23e-26 | 1187 | 46 | 30 | GO:0099081 |
| GeneOntologyCellularComponent | keratin filament | KRTAP9-7 KRTAP2-3 KRTAP2-1 KRTAP5-2 KRTAP9-6 KRTAP4-16 KRTAP2-4 KRTAP1-4 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 1.71e-22 | 97 | 46 | 14 | GO:0045095 |
| GeneOntologyCellularComponent | lytic vacuole | 1.84e-03 | 811 | 46 | 7 | GO:0000323 | |
| GeneOntologyCellularComponent | lysosome | 1.84e-03 | 811 | 46 | 7 | GO:0005764 | |
| GeneOntologyCellularComponent | vacuole | 3.58e-03 | 913 | 46 | 7 | GO:0005773 | |
| MousePheno | increased thigmotaxis | KRTAP9-7 KRTAP9-6 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-3 KRTAP9-8 | 1.85e-11 | 132 | 14 | 7 | MP:0002797 |
| MousePheno | abnormal tooth color | 2.91e-10 | 40 | 14 | 5 | MP:0013129 | |
| MousePheno | increased kidney weight | 3.15e-09 | 145 | 14 | 6 | MP:0003917 | |
| MousePheno | hypoactivity | KRTAP9-7 MDFIC XKR4 KRTAP9-6 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 3.22e-09 | 1023 | 14 | 10 | MP:0031392 |
| MousePheno | increased anxiety-related response | KRTAP9-7 KRTAP9-6 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-3 KRTAP9-8 | 7.57e-09 | 311 | 14 | 7 | MP:0001363 |
| MousePheno | decreased locomotor activity | KRTAP9-7 XKR4 KRTAP9-6 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 1.33e-08 | 829 | 14 | 9 | MP:0001402 |
| MousePheno | abnormal kidney weight | 2.75e-08 | 208 | 14 | 6 | MP:0002707 | |
| MousePheno | enlarged kidney | 6.39e-07 | 354 | 14 | 6 | MP:0003068 | |
| MousePheno | abnormal anxiety-related response | KRTAP9-7 KRTAP9-6 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-3 KRTAP9-8 | 2.80e-06 | 740 | 14 | 7 | MP:0001362 |
| MousePheno | hyperactivity | KRTAP9-7 KRTAP9-6 PCDH10 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-3 KRTAP9-8 | 4.53e-06 | 1172 | 14 | 8 | MP:0001399 |
| MousePheno | enlarged thymus | 6.59e-06 | 292 | 14 | 5 | MP:0000709 | |
| MousePheno | abnormal tooth morphology | 9.98e-06 | 318 | 14 | 5 | MP:0002100 | |
| MousePheno | abnormal dental arch morphology | 1.01e-05 | 319 | 14 | 5 | MP:0030254 | |
| MousePheno | abnormal fear/anxiety-related behavior | KRTAP9-7 KRTAP9-6 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-3 KRTAP9-8 | 1.18e-05 | 919 | 14 | 7 | MP:0002065 |
| MousePheno | abnormal kidney size | 3.67e-05 | 714 | 14 | 6 | MP:0002706 | |
| MousePheno | abnormal jaw morphology | 1.16e-04 | 530 | 14 | 5 | MP:0000454 | |
| MousePheno | abnormal thymus size | 1.55e-04 | 564 | 14 | 5 | MP:0002364 | |
| MousePheno | abnormal viscerocranium morphology | 1.97e-04 | 593 | 14 | 5 | MP:0005274 | |
| MousePheno | abnormal mouth morphology | 3.47e-04 | 670 | 14 | 5 | MP:0000452 | |
| MousePheno | abnormal thymus morphology | 4.76e-04 | 717 | 14 | 5 | MP:0000703 | |
| MousePheno | abnormal cranium morphology | 8.46e-04 | 813 | 14 | 5 | MP:0000438 | |
| MousePheno | abnormal craniofacial bone morphology | 9.15e-04 | 827 | 14 | 5 | MP:0002116 | |
| MousePheno | abnormal kidney morphology | 1.28e-03 | 1363 | 14 | 6 | MP:0002135 | |
| MousePheno | abnormal facial morphology | 1.41e-03 | 910 | 14 | 5 | MP:0003743 | |
| MousePheno | abnormal axial skeleton morphology | 1.83e-03 | 1458 | 14 | 6 | MP:0002114 | |
| MousePheno | abnormal head morphology | 3.55e-03 | 1120 | 14 | 5 | MP:0000432 | |
| MousePheno | abnormal endocrine gland morphology | 3.89e-03 | 1144 | 14 | 5 | MP:0013560 | |
| MousePheno | craniofacial phenotype | 8.50e-03 | 1372 | 14 | 5 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 8.50e-03 | 1372 | 14 | 5 | MP:0000428 | |
| Domain | KAP | KRTAP9-7 KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-10 KRTAP2-1 KRTAP5-6 KRTAP5-2 KRTAP2-2 KRTAP9-6 KRTAP5-8 KRTAP5-5 KRTAP2-4 KRTAP1-4 KRTAP5-7 KRTAP9-1 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 3.66e-52 | 58 | 41 | 24 | IPR002494 |
| Domain | Keratin_B2 | KRTAP5-4 KRTAP5-9 KRTAP2-3 KRTAP2-1 KRTAP5-2 KRTAP2-2 KRTAP5-5 KRTAP2-4 KRTAP1-4 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 2.77e-31 | 40 | 41 | 15 | PF01500 |
| Domain | Keratin_B2_2 | KRTAP9-7 KRTAP5-4 KRTAP2-3 KRTAP5-10 KRTAP5-2 KRTAP2-2 KRTAP9-6 KRTAP5-5 KRTAP9-1 KRTAP5-11 KRTAP9-2 KRTAP9-8 | 7.93e-24 | 39 | 41 | 12 | PF13885 |
| Domain | Metalthion_dom_vert | 1.01e-22 | 12 | 41 | 9 | IPR023587 | |
| Domain | Metalthion_dom | 1.01e-22 | 12 | 41 | 9 | IPR017854 | |
| Domain | - | 1.01e-22 | 12 | 41 | 9 | 4.10.10.10 | |
| Domain | Metalthion_vert | 9.15e-22 | 14 | 41 | 9 | IPR000006 | |
| Domain | Metalthion | 9.15e-22 | 14 | 41 | 9 | IPR003019 | |
| Domain | Metallothio | 9.15e-22 | 14 | 41 | 9 | PF00131 | |
| Domain | Metalthion_vert_metal_BS | 1.17e-20 | 10 | 41 | 8 | IPR018064 | |
| Domain | METALLOTHIONEIN_VRT | 3.33e-19 | 13 | 41 | 8 | PS00203 | |
| Domain | MDFI/MDFIC | 4.70e-06 | 2 | 41 | 2 | IPR026134 | |
| Domain | MDFI | 4.70e-06 | 2 | 41 | 2 | PF15316 | |
| Domain | TDE1/TMS | 4.68e-05 | 5 | 41 | 2 | IPR005016 | |
| Domain | Serinc | 4.68e-05 | 5 | 41 | 2 | PF03348 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP9-7 KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-10 KRTAP2-1 KRTAP5-6 KRTAP5-2 KRTAP2-2 KRTAP9-6 KRTAP5-8 KRTAP5-5 KRTAP2-4 KRTAP1-4 KRTAP5-7 KRTAP9-1 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 6.08e-38 | 217 | 36 | 25 | M27640 |
| Pathway | REACTOME_KERATINIZATION | KRTAP9-7 KRTAP5-4 KRTAP2-3 KRTAP2-1 KRTAP5-6 KRTAP5-2 KRTAP2-2 KRTAP9-6 KRTAP5-8 KRTAP5-5 KRTAP2-4 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 1.17e-24 | 153 | 36 | 17 | MM15343 |
| Pathway | REACTOME_METALLOTHIONEINS_BIND_METALS | 1.29e-19 | 11 | 36 | 8 | M27543 | |
| Pathway | REACTOME_RESPONSE_TO_METAL_IONS | 2.33e-18 | 14 | 36 | 8 | M27541 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP9-7 KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-10 KRTAP2-1 KRTAP5-6 KRTAP5-2 KRTAP2-2 KRTAP9-6 KRTAP5-8 KRTAP5-5 KRTAP2-4 KRTAP1-4 KRTAP5-7 KRTAP9-1 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 2.42e-17 | 1432 | 36 | 25 | M509 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP9-7 KRTAP5-4 KRTAP2-3 KRTAP2-1 KRTAP5-6 KRTAP5-2 KRTAP2-2 KRTAP9-6 KRTAP5-8 KRTAP5-5 KRTAP2-4 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 8.39e-16 | 502 | 36 | 17 | MM14537 |
| Pathway | WP_ZINC_HOMEOSTASIS | 2.88e-14 | 37 | 36 | 8 | M39377 | |
| Pathway | WP_OXIDATIVE_STRESS_RESPONSE | 3.02e-12 | 36 | 36 | 7 | MM15941 | |
| Pathway | WP_COPPER_HOMEOSTASIS | 5.40e-11 | 53 | 36 | 7 | M39349 | |
| Pathway | WP_LUNG_FIBROSIS | 2.69e-08 | 73 | 36 | 6 | MM15827 | |
| Pathway | REACTOME_SERINE_BIOSYNTHESIS | 2.26e-04 | 9 | 36 | 2 | M27959 | |
| Pathway | REACTOME_SERINE_BIOSYNTHESIS | 2.26e-04 | 9 | 36 | 2 | MM15707 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 9.51e-04 | 828 | 36 | 8 | M27827 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 1.60e-03 | 505 | 36 | 6 | MM15548 | |
| Pubmed | KRTAP9-7 KRTAP2-1 KRTAP5-2 KRTAP9-6 SCYGR3 SCYGR1 SCYGR2 KRTAP5-5 SCYGR5 KRTAP9-1 KRTAP1-5 SCYGR9 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 5.43e-35 | 69 | 48 | 17 | 18721477 | |
| Pubmed | KRTAP9-7 KRTAP2-3 KRTAP2-1 KRTAP2-2 KRTAP9-6 KRTAP4-16 KRTAP2-4 KRTAP1-4 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 9.99e-35 | 37 | 48 | 15 | 11279113 | |
| Pubmed | KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP5-10 KRTAP5-6 KRTAP5-2 KRTAP5-8 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 7.81e-31 | 13 | 48 | 11 | 15144888 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 22363575 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 1779826 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 16049321 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 16432836 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 30557628 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 10505629 | ||
| Pubmed | Down-regulation of metallothionein 1 and 2 after exposure to electromagnetic field in mouse testis. | 6.40e-23 | 9 | 48 | 8 | 22395140 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 11850030 | ||
| Pubmed | Blockade of Metallothioneins 1 and 2 Increases Skeletal Muscle Mass and Strength. | 6.40e-23 | 9 | 48 | 8 | 27956698 | |
| Pubmed | Regulation, linkage, and sequence of mouse metallothionein I and II genes. | 6.40e-23 | 9 | 48 | 8 | 6095054 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 28426713 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 18449439 | ||
| Pubmed | Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine in mice. | 6.40e-23 | 9 | 48 | 8 | 10426817 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 15735556 | ||
| Pubmed | Atrophy of large myelinated axons in metallothionein-I, II knockout mice. | 6.40e-23 | 9 | 48 | 8 | 16133945 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 21913972 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 15979673 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 15306638 | ||
| Pubmed | Cytoprotection by metallothionein against gastroduodenal mucosal injury caused by ethanol in mice. | 6.40e-23 | 9 | 48 | 8 | 10744072 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 9176863 | ||
| Pubmed | Metallothionein deficiency aggravates depleted uranium-induced nephrotoxicity. | 6.40e-23 | 9 | 48 | 8 | 26148447 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 2019319 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 26267326 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 19837066 | ||
| Pubmed | Zinc treatment prevents lipopolysaccharide-induced teratogenicity in mice. | 6.40e-23 | 9 | 48 | 8 | 12854659 | |
| Pubmed | Cadmium modulates adipocyte functions in metallothionein-null mice. | 6.40e-23 | 9 | 48 | 8 | 23921151 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 25761970 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 11792622 | ||
| Pubmed | Metallothionein-null mice express altered genes during development. | 6.40e-23 | 9 | 48 | 8 | 10753647 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 16150881 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 10764993 | ||
| Pubmed | Metallothionein-1+2 protect the CNS after a focal brain injury. | 6.40e-23 | 9 | 48 | 8 | 11771944 | |
| Pubmed | Augmented humoral immune function in metallothionein-null mice. | 6.40e-23 | 9 | 48 | 8 | 10906280 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 19828842 | ||
| Pubmed | Development of a compartmental model of zinc kinetics in mice. | 6.40e-23 | 9 | 48 | 8 | 18936212 | |
| Pubmed | Metallothionein, an endogenous antioxidant, protects against retinal neuron damage in mice. | 6.40e-23 | 9 | 48 | 8 | 16936113 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 10947810 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 11585628 | ||
| Pubmed | Epidermal proliferation of the skin in metallothionein-null mice. | 6.40e-23 | 9 | 48 | 8 | 9506445 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 19254786 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 11950277 | ||
| Pubmed | Decreased neurofilament density in large myelinated axons of metallothionein-I, II knockout mice. | 6.40e-23 | 9 | 48 | 8 | 16600496 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 18083145 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 17031522 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 35454172 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 10788577 | ||
| Pubmed | Metallothionein-null mice exhibit reduced tolerance to ultraviolet B injury in vivo. | 6.40e-23 | 9 | 48 | 8 | 14723724 | |
| Pubmed | Metallothionein regulates intracellular zinc signaling during CD4(+) T cell activation. | 6.40e-23 | 9 | 48 | 8 | 27251638 | |
| Pubmed | Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity. | 6.40e-23 | 9 | 48 | 8 | 9512723 | |
| Pubmed | Metallothionein-I/II null mice are sensitive to chronic oral cadmium-induced nephrotoxicity. | 6.40e-23 | 9 | 48 | 8 | 10966523 | |
| Pubmed | Trace metal, acute phase and metabolic response to endotoxin in metallothionein-null mice. | 6.40e-23 | 9 | 48 | 8 | 8615771 | |
| Pubmed | Mercury-induced cognitive impairment in metallothionein-1/2 null mice. | 6.40e-23 | 9 | 48 | 8 | 18226494 | |
| Pubmed | Metallothionein expression and neurocognitive function in mice. | 6.40e-23 | 9 | 48 | 8 | 16430929 | |
| Pubmed | Protective effects of metallothionein on isoniazid and rifampicin-induced hepatotoxicity in mice. | 6.40e-23 | 9 | 48 | 8 | 23967274 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 12613667 | ||
| Pubmed | Distribution and retention of mercury in metallothionen-null mice after exposure to mercury vapor. | 6.40e-23 | 9 | 48 | 8 | 10614694 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 18579766 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 20798270 | ||
| Pubmed | Using MT(-/-) mice to study metallothionein and oxidative stress. | 6.40e-23 | 9 | 48 | 8 | 10699757 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 10495773 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 23467591 | ||
| Pubmed | Cadmium-induced mRNA expression of Hsp32 is augmented in metallothionein-I and -II knock-out mice. | 6.40e-23 | 9 | 48 | 8 | 11051100 | |
| Pubmed | Mammalian MT1 and MT2 metallothioneins differ in their metal binding abilities. | 6.40e-23 | 9 | 48 | 8 | 23925449 | |
| Pubmed | Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide. | 6.40e-23 | 9 | 48 | 8 | 11835189 | |
| Pubmed | Infection of metallothionein 1+2 knockout mice with Rocky Mountain Laboratory scrapie. | 6.40e-23 | 9 | 48 | 8 | 18221736 | |
| Pubmed | Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. | 6.40e-23 | 9 | 48 | 8 | 8290567 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 27403038 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 15639482 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 15161632 | ||
| Pubmed | Role of metallothioneins as danger signals in the pathogenesis of colitis. | 6.40e-23 | 9 | 48 | 8 | 24452846 | |
| Pubmed | Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity. | 6.40e-23 | 9 | 48 | 8 | 10087053 | |
| Pubmed | Deficiency of metallothionein-1 and -2 genes shortens the lifespan of the 129/Sv mouse strain. | 6.40e-23 | 9 | 48 | 8 | 25871729 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 18239062 | ||
| Pubmed | CNS wound healing is severely depressed in metallothionein I- and II-deficient mice. | 6.40e-23 | 9 | 48 | 8 | 10087067 | |
| Pubmed | Impaired hepatic regeneration in metallothionein-I/II knockout mice after partial hepatectomy. | 6.40e-23 | 9 | 48 | 8 | 15618127 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 8619230 | ||
| Pubmed | Distribution and retention of cadmium in metallothionein I and II null mice. | 6.40e-23 | 9 | 48 | 8 | 8619234 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 8914622 | ||
| Pubmed | Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. | 6.40e-23 | 9 | 48 | 8 | 9419380 | |
| Pubmed | Helicobacter-induced gastritis in mice not expressing metallothionein-I and II. | 6.40e-23 | 9 | 48 | 8 | 14536000 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 14499492 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 10828279 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 10736338 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 17409522 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 22152221 | ||
| Pubmed | Gene expression profiles in the liver and kidney of metallothionein-null mice. | 6.40e-23 | 9 | 48 | 8 | 15913548 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 16387980 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 20144643 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 16563532 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 2576352 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 12807749 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 15520181 | ||
| Pubmed | Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity. | 6.40e-23 | 9 | 48 | 8 | 17910954 | |
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 12098501 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 24138881 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 14692620 | ||
| Pubmed | 6.40e-23 | 9 | 48 | 8 | 15071173 | ||
| Interaction | LCE3A interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 MDFI KRTAP5-8 KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 8.55e-35 | 76 | 38 | 18 | int:LCE3A |
| Interaction | LCE1E interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-6 KRTAP5-2 KRTAP5-8 KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 8.81e-31 | 68 | 38 | 16 | int:LCE1E |
| Interaction | LCE3D interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-6 KRTAP5-2 MDFI KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 3.14e-30 | 73 | 38 | 16 | int:LCE3D |
| Interaction | KRTAP4-4 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 1.99e-29 | 81 | 38 | 16 | int:KRTAP4-4 |
| Interaction | LCE2B interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 MDFI KRTAP2-4 KRTAP5-7 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 1.99e-29 | 81 | 38 | 16 | int:LCE2B |
| Interaction | LCE3E interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-6 KRTAP5-2 MDFI KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 2.81e-29 | 60 | 38 | 15 | int:LCE3E |
| Interaction | LCE1A interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 MDFI KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 3.77e-29 | 84 | 38 | 16 | int:LCE1A |
| Interaction | LCE1B interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-6 KRTAP5-2 MDFI KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 4.63e-29 | 85 | 38 | 16 | int:LCE1B |
| Interaction | LCE2C interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 8.50e-29 | 88 | 38 | 16 | int:LCE2C |
| Interaction | LCE1F interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 MDFI KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 1.84e-28 | 92 | 38 | 16 | int:LCE1F |
| Interaction | LCE1D interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 MDFI KRTAP2-4 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 3.77e-28 | 70 | 38 | 15 | int:LCE1D |
| Interaction | LCE4A interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 CRCT1 KRTAP5-6 KRTAP5-2 MDFI KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 3.43e-27 | 80 | 38 | 15 | int:LCE4A |
| Interaction | KRTAP4-11 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP2-4 KRTAP5-7 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 3.34e-26 | 92 | 38 | 15 | int:KRTAP4-11 |
| Interaction | KRTAP5-11 interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 3.39e-26 | 66 | 38 | 14 | int:KRTAP5-11 |
| Interaction | LCE3C interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-6 KRTAP5-2 MDFI KRTAP2-4 KRTAP5-11 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 4.29e-26 | 67 | 38 | 14 | int:LCE3C |
| Interaction | KRTAP5-6 interactions | KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 4.73e-26 | 94 | 38 | 15 | int:KRTAP5-6 |
| Interaction | LCE2A interactions | KRTAP5-4 KRTAP5-9 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 6.76e-26 | 69 | 38 | 14 | int:LCE2A |
| Interaction | LCE2D interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-6 KRTAP5-2 KRTAP2-4 KRTAP5-7 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 1.98e-25 | 74 | 38 | 14 | int:LCE2D |
| Interaction | SMCP interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 MT1B KRTAP5-6 KRTAP5-2 MT1M KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 5.38e-25 | 79 | 38 | 14 | int:SMCP |
| Interaction | KRTAP9-2 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 6.75e-25 | 149 | 38 | 16 | int:KRTAP9-2 |
| Interaction | KRTAP10-1 interactions | KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 1.05e-24 | 153 | 38 | 16 | int:KRTAP10-1 |
| Interaction | KRTAP5-2 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 MT1B CRCT1 KRTAP5-6 KRTAP5-2 KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP9-2 KRTAP9-8 | 2.94e-24 | 62 | 38 | 13 | int:KRTAP5-2 |
| Interaction | KRTAP5-4 interactions | KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP5-7 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 3.70e-24 | 63 | 38 | 13 | int:KRTAP5-4 |
| Interaction | LCE5A interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-6 KRTAP5-2 KRTAP5-8 KRTAP2-4 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 3.86e-24 | 90 | 38 | 14 | int:LCE5A |
| Interaction | KRTAP9-8 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP2-4 KRTAP5-11 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 1.86e-23 | 100 | 38 | 14 | int:KRTAP9-8 |
| Interaction | CREB5 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-6 KRTAP5-2 MDFI KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 3.11e-22 | 164 | 38 | 15 | int:CREB5 |
| Interaction | CATSPER1 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-6 MDFI KRTAP2-4 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 5.65e-22 | 126 | 38 | 14 | int:CATSPER1 |
| Interaction | CRCT1 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP5-8 KRTAP5-7 KRTAP5-11 KRTAP9-2 KRTAP1-3 KRTAP9-8 | 1.34e-21 | 66 | 38 | 12 | int:CRCT1 |
| Interaction | KRTAP5-3 interactions | KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 1.34e-21 | 66 | 38 | 12 | int:KRTAP5-3 |
| Interaction | LCE3B interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP5-6 KRTAP5-2 KRTAP5-7 KRTAP5-11 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 2.76e-21 | 46 | 38 | 11 | int:LCE3B |
| Interaction | KRTAP4-5 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP5-7 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 8.33e-21 | 76 | 38 | 12 | int:KRTAP4-5 |
| Interaction | OTX1 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-6 MDFI KRTAP2-4 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 1.15e-20 | 155 | 38 | 14 | int:OTX1 |
| Interaction | KRTAP4-2 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 1.05e-19 | 132 | 38 | 13 | int:KRTAP4-2 |
| Interaction | KRTAP9-3 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP2-4 KRTAP5-11 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 2.32e-19 | 140 | 38 | 13 | int:KRTAP9-3 |
| Interaction | KRTAP5-9 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 MT1M KRTAP2-4 KRTAP5-11 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 5.50e-19 | 203 | 38 | 14 | int:KRTAP5-9 |
| Interaction | LCE1C interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP2-4 KRTAP5-11 KRTAP9-2 KRTAP9-8 | 1.33e-18 | 77 | 38 | 11 | int:LCE1C |
| Interaction | KRTAP10-5 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP2-4 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 1.38e-18 | 160 | 38 | 13 | int:KRTAP10-5 |
| Interaction | PHLDA1 interactions | KRTAP5-1 KRTAP5-9 KRTAP2-3 MDFI KRTAP2-4 KRTAP5-7 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 3.06e-17 | 66 | 38 | 10 | int:PHLDA1 |
| Interaction | KRTAP4-12 interactions | KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP2-4 KRTAP5-7 KRTAP9-2 KRTAP1-1 KRTAP1-3 | 1.01e-16 | 161 | 38 | 12 | int:KRTAP4-12 |
| Interaction | LELP1 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP5-6 KRTAP5-2 KRTAP5-11 KRTAP9-2 | 9.05e-16 | 17 | 38 | 7 | int:LELP1 |
| Interaction | HOXA1 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-6 KRTAP5-2 MDFI KRTAP2-4 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 1.47e-15 | 356 | 38 | 14 | int:HOXA1 |
| Interaction | WNT11 interactions | KRTAP5-9 MDFI KRTAP5-8 KRTAP5-7 KRTAP1-5 KRTAP1-1 KRTAP1-3 KRTAP17-1 | 1.65e-15 | 35 | 38 | 8 | int:WNT11 |
| Interaction | SHFL interactions | KRTAP5-9 KRTAP2-3 MDFI KRTAP2-4 KRTAP5-7 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP17-1 | 1.75e-15 | 97 | 38 | 10 | int:SHFL |
| Interaction | KRTAP10-11 interactions | KRTAP5-9 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP5-7 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 2.77e-15 | 64 | 38 | 9 | int:KRTAP10-11 |
| Interaction | VASN interactions | KRTAP5-4 KRTAP2-3 KRTAP5-6 MDFI KRTAP2-4 KRTAP5-11 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 5.58e-15 | 160 | 38 | 11 | int:VASN |
| Interaction | CYSRT1 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 MT1M KRTAP2-4 KRTAP5-7 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 8.51e-15 | 511 | 38 | 15 | int:CYSRT1 |
| Interaction | NUFIP2 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-6 KRTAP5-2 MDFI KRTAP2-4 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 1.31e-14 | 417 | 38 | 14 | int:NUFIP2 |
| Interaction | KRTAP10-9 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP5-7 KRTAP5-11 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 1.34e-14 | 241 | 38 | 12 | int:KRTAP10-9 |
| Interaction | ZDHHC1 interactions | 2.21e-14 | 25 | 38 | 7 | int:ZDHHC1 | |
| Interaction | DMRT3 interactions | KRTAP5-9 KRTAP2-3 MDFI KRTAP2-4 KRTAP5-7 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 | 5.01e-14 | 87 | 38 | 9 | int:DMRT3 |
| Interaction | HHEX interactions | KRTAP5-9 KRTAP2-3 MDFI KRTAP5-8 KRTAP2-4 KRTAP5-7 KRTAP1-1 KRTAP1-3 | 7.10e-14 | 54 | 38 | 8 | int:HHEX |
| Interaction | KRTAP1-1 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 MT1B KRTAP5-6 KRTAP2-4 KRTAP5-11 KRTAP9-2 KRTAP1-1 KRTAP9-8 | 1.80e-13 | 219 | 38 | 11 | int:KRTAP1-1 |
| Interaction | ZNF440 interactions | 8.41e-13 | 40 | 38 | 7 | int:ZNF440 | |
| Interaction | HOXB9 interactions | KRTAP5-9 KRTAP2-3 MDFI KRTAP2-4 KRTAP5-7 KRTAP1-5 KRTAP1-1 KRTAP1-3 KRTAP17-1 | 1.32e-12 | 124 | 38 | 9 | int:HOXB9 |
| Interaction | SLC13A5 interactions | 1.58e-12 | 21 | 38 | 6 | int:SLC13A5 | |
| Interaction | SDC3 interactions | KRTAP5-9 KRTAP2-3 KRTAP2-4 KRTAP5-7 KRTAP9-2 KRTAP1-1 KRTAP1-3 | 1.72e-12 | 44 | 38 | 7 | int:SDC3 |
| Interaction | POU4F2 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP5-6 KRTAP5-11 KRTAP9-2 KRTAP1-1 KRTAP9-8 | 2.59e-12 | 83 | 38 | 8 | int:POU4F2 |
| Interaction | KRTAP17-1 interactions | 3.29e-12 | 48 | 38 | 7 | int:KRTAP17-1 | |
| Interaction | SPATA3 interactions | 3.90e-12 | 24 | 38 | 6 | int:SPATA3 | |
| Interaction | KRTAP10-6 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 MT1B KRTAP5-6 KRTAP5-2 KRTAP5-11 KRTAP9-8 | 4.19e-12 | 88 | 38 | 8 | int:KRTAP10-6 |
| Interaction | DHRS1 interactions | 5.15e-12 | 51 | 38 | 7 | int:DHRS1 | |
| Interaction | KRTAP10-8 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP5-11 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 5.55e-12 | 401 | 38 | 12 | int:KRTAP10-8 |
| Interaction | KRTAP2-3 interactions | KRTAP5-9 KRTAP2-3 KRTAP5-2 KRTAP2-4 KRTAP5-11 KRTAP9-2 KRTAP1-1 KRTAP9-8 | 7.86e-12 | 95 | 38 | 8 | int:KRTAP2-3 |
| Interaction | ZNF575 interactions | 8.54e-12 | 27 | 38 | 6 | int:ZNF575 | |
| Interaction | JOSD1 interactions | 1.02e-11 | 56 | 38 | 7 | int:JOSD1 | |
| Interaction | KLHL38 interactions | KRTAP5-9 KRTAP2-3 MDFI KRTAP2-4 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 1.10e-11 | 99 | 38 | 8 | int:KLHL38 |
| Interaction | KRTAP2-4 interactions | KRTAP5-9 KRTAP2-3 KRTAP5-2 KRTAP2-4 KRTAP5-11 KRTAP9-2 KRTAP1-1 KRTAP9-8 | 1.30e-11 | 101 | 38 | 8 | int:KRTAP2-4 |
| Interaction | KRTAP5-1 interactions | 2.31e-11 | 13 | 38 | 5 | int:KRTAP5-1 | |
| Interaction | DOCK2 interactions | 3.39e-11 | 66 | 38 | 7 | int:DOCK2 | |
| Interaction | KRTAP1-3 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 CRCT1 KRTAP5-6 KRTAP5-11 KRTAP9-2 KRTAP1-3 KRTAP9-8 | 4.70e-11 | 184 | 38 | 9 | int:KRTAP1-3 |
| Interaction | ADAMTSL3 interactions | 5.37e-11 | 15 | 38 | 5 | int:ADAMTSL3 | |
| Interaction | KRTAP5-7 interactions | KRTAP5-4 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP5-7 KRTAP5-11 KRTAP9-2 | 5.75e-11 | 71 | 38 | 7 | int:KRTAP5-7 |
| Interaction | ITGB4 interactions | KRTAP2-3 MDFI KRTAP2-4 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 7.31e-11 | 125 | 38 | 8 | int:ITGB4 |
| Interaction | CRY2 interactions | KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP5-2 KRTAP5-7 KRTAP1-1 KRTAP1-3 KRTAP9-8 | 7.55e-11 | 194 | 38 | 9 | int:CRY2 |
| Interaction | MAPKBP1 interactions | 7.75e-11 | 74 | 38 | 7 | int:MAPKBP1 | |
| Interaction | MT1M interactions | 1.53e-10 | 18 | 38 | 5 | int:MT1M | |
| Interaction | MT1B interactions | 1.61e-10 | 6 | 38 | 4 | int:MT1B | |
| Interaction | ADAMTSL4 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP5-6 KRTAP5-2 KRTAP5-7 KRTAP1-5 KRTAP9-2 KRTAP1-1 | 2.05e-10 | 217 | 38 | 9 | int:ADAMTSL4 |
| Interaction | KRTAP1-5 interactions | 3.44e-10 | 48 | 38 | 6 | int:KRTAP1-5 | |
| Interaction | NKD1 interactions | 3.61e-10 | 21 | 38 | 5 | int:NKD1 | |
| Interaction | ZNF786 interactions | 3.61e-10 | 21 | 38 | 5 | int:ZNF786 | |
| Interaction | NBPF19 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-6 KRTAP2-4 KRTAP5-11 KRTAP9-2 KRTAP9-8 | 3.85e-10 | 233 | 38 | 9 | int:NBPF19 |
| Interaction | PRKAB2 interactions | KRTAP5-9 KRTAP2-3 MDFI KRTAP2-4 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 4.00e-10 | 234 | 38 | 9 | int:PRKAB2 |
| Interaction | CRH interactions | 4.66e-10 | 22 | 38 | 5 | int:CRH | |
| Interaction | GNE interactions | 8.79e-10 | 104 | 38 | 7 | int:GNE | |
| Interaction | ADAM12 interactions | 1.12e-09 | 58 | 38 | 6 | int:ADAM12 | |
| Interaction | KRTAP11-1 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP5-6 KRTAP5-11 KRTAP9-2 KRTAP9-8 | 1.15e-09 | 108 | 38 | 7 | int:KRTAP11-1 |
| Interaction | CNNM3 interactions | KRTAP5-9 MDFI KRTAP2-4 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 1.29e-09 | 179 | 38 | 8 | int:CNNM3 |
| Interaction | NOTCH2NLA interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 CRCT1 KRTAP5-6 KRTAP2-4 KRTAP5-11 KRTAP9-2 KRTAP9-8 | 1.53e-09 | 381 | 38 | 10 | int:NOTCH2NLA |
| Interaction | RGS20 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 CRCT1 KRTAP5-6 KRTAP5-11 KRTAP9-8 | 2.14e-09 | 118 | 38 | 7 | int:RGS20 |
| Interaction | GLRX3 interactions | KRTAP5-9 KRTAP5-3 KRTAP5-6 MDFI KRTAP5-11 KRTAP9-2 KRTAP1-3 KRTAP9-8 | 2.15e-09 | 191 | 38 | 8 | int:GLRX3 |
| Interaction | NPDC1 interactions | 2.26e-09 | 65 | 38 | 6 | int:NPDC1 | |
| Interaction | KRTAP10-7 interactions | KRTAP5-4 KRTAP5-9 KRTAP5-3 CRCT1 KRTAP5-6 KRTAP5-2 KRTAP5-11 KRTAP9-2 KRTAP9-8 | 2.89e-09 | 293 | 38 | 9 | int:KRTAP10-7 |
| Interaction | ZNF696 interactions | 2.99e-09 | 68 | 38 | 6 | int:ZNF696 | |
| Interaction | NR4A3 interactions | 3.27e-09 | 69 | 38 | 6 | int:NR4A3 | |
| Interaction | VGLL3 interactions | 4.24e-09 | 72 | 38 | 6 | int:VGLL3 | |
| Interaction | CHIC2 interactions | 4.61e-09 | 73 | 38 | 6 | int:CHIC2 | |
| Interaction | ZNF587 interactions | 5.49e-09 | 135 | 38 | 7 | int:ZNF587 | |
| Interaction | GUCD1 interactions | 1.44e-08 | 88 | 38 | 6 | int:GUCD1 | |
| Interaction | CXCL16 interactions | 1.54e-08 | 89 | 38 | 6 | int:CXCL16 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | KRTAP9-7 KRTAP2-3 KRTAP2-1 KRTAP2-2 KRTAP9-6 KRTAP4-16 KRTAP2-4 KRTAP1-4 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 1.00e-18 | 473 | 48 | 15 | chr17q21 |
| Cytoband | 17q12-q21 | KRTAP2-1 KRTAP9-6 KRTAP4-16 KRTAP1-5 KRTAP9-2 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 7.97e-18 | 32 | 48 | 8 | 17q12-q21 |
| Cytoband | 16q13 | 2.28e-17 | 36 | 48 | 8 | 16q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q13 | 5.79e-17 | 40 | 48 | 8 | chr16q13 | |
| Cytoband | 17q21.2 | 1.18e-10 | 70 | 48 | 6 | 17q21.2 | |
| Cytoband | 11p15.5 | 2.85e-09 | 118 | 48 | 6 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q36 | 3.11e-08 | 85 | 48 | 5 | chr2q36 | |
| Cytoband | 11q13.4 | 1.21e-06 | 75 | 48 | 4 | 11q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 2.65e-05 | 564 | 48 | 6 | chr11p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 1.12e-04 | 454 | 48 | 5 | chr11q13 | |
| GeneFamily | Keratin associated proteins | KRTAP9-7 KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-10 KRTAP2-1 KRTAP5-6 KRTAP5-2 KRTAP2-2 KRTAP9-6 KRTAP5-8 KRTAP4-16 KRTAP5-5 KRTAP2-4 KRTAP1-4 KRTAP5-7 KRTAP9-1 KRTAP5-11 KRTAP1-5 KRTAP9-2 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 6.23e-51 | 109 | 37 | 26 | 619 |
| GeneFamily | Metallothioneins | 2.00e-20 | 19 | 37 | 9 | 638 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | KRTAP9-7 MT1B MT1E MT1F MT1H KRTAP5-2 MT1X MT2A KRTAP9-6 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-3 KRTAP9-8 | 8.32e-20 | 204 | 42 | 14 | MM966 |
| Coexpression | RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_0W_14W_METALLOTHIONEIN_SUBSET_UP | 1.28e-19 | 8 | 42 | 7 | M41082 | |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 4.64e-17 | 27 | 42 | 8 | MM643 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | KRTAP9-7 MT1A MT1B MT1E MT1F MT1H KRTAP5-2 MT1M MT1X MT2A KRTAP9-6 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-3 KRTAP9-8 | 1.56e-15 | 650 | 42 | 16 | MM1042 |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | KRTAP9-7 MT1A MT1B MT1E MT1F MT1H KRTAP5-2 MT1M MT1X MT2A KRTAP9-6 KRTAP9-1 KRTAP1-5 KRTAP9-2 KRTAP1-3 KRTAP9-8 | 1.93e-15 | 659 | 42 | 16 | MM1040 |
| Coexpression | VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP | 2.68e-15 | 22 | 42 | 7 | MM1299 | |
| Coexpression | HOUSTIS_ROS | 3.64e-15 | 44 | 42 | 8 | MM1142 | |
| Coexpression | SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP | 7.71e-15 | 48 | 42 | 8 | MM649 | |
| Coexpression | LUDWICZEK_TREATING_IRON_OVERLOAD | 1.07e-14 | 12 | 42 | 6 | MM792 | |
| Coexpression | PIONTEK_PKD1_TARGETS_UP | 1.30e-14 | 51 | 42 | 8 | MM794 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP | 1.85e-14 | 28 | 42 | 7 | MM487 | |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_UP | 4.47e-14 | 59 | 42 | 8 | MM952 | |
| Coexpression | ZHENG_RESPONSE_TO_ARSENITE_UP | 5.77e-14 | 15 | 42 | 6 | M1589 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP | 9.22e-14 | 16 | 42 | 6 | MM1089 | |
| Coexpression | BRACHAT_RESPONSE_TO_METHOTREXATE_DN | 1.95e-13 | 38 | 42 | 7 | MM1161 | |
| Coexpression | MA_MYELOID_DIFFERENTIATION_UP | 8.19e-13 | 46 | 42 | 7 | MM640 | |
| Coexpression | SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP | 1.15e-12 | 23 | 42 | 6 | MM1198 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_UP | 1.97e-12 | 93 | 42 | 8 | MM850 | |
| Coexpression | WANG_TARGETS_OF_MLL_CBP_FUSION_UP | 2.03e-12 | 52 | 42 | 7 | MM628 | |
| Coexpression | HEVNER_CORTEX_CAUDAL_VENTRICULAR_ZONE | 2.03e-12 | 52 | 42 | 7 | MM442 | |
| Coexpression | LEIN_ASTROCYTE_MARKERS | 2.68e-12 | 54 | 42 | 7 | MM715 | |
| Coexpression | BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN | 2.68e-12 | 54 | 42 | 7 | MM1195 | |
| Coexpression | ZHANG_UTERUS_C2_REGENERATIVE_UP | 2.79e-12 | 97 | 42 | 8 | MM16605 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 3.58e-12 | 100 | 42 | 8 | MM514 | |
| Coexpression | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP | 4.28e-12 | 28 | 42 | 6 | MM707 | |
| Coexpression | JIANG_AGING_HYPOTHALAMUS_UP | 4.54e-12 | 58 | 42 | 7 | MM703 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_CARDIOMYOCYTE_AGEING | 2.34e-11 | 126 | 42 | 8 | MM3711 | |
| Coexpression | MA_RAT_AGING_UP | 2.50e-11 | 127 | 42 | 8 | MM16096 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 4.34e-11 | 136 | 42 | 8 | MM3747 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 | 6.63e-11 | 84 | 42 | 7 | MM873 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP | 3.42e-10 | 176 | 42 | 8 | MM1048 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 4.81e-10 | 111 | 42 | 7 | MM705 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP | 5.09e-10 | 185 | 42 | 8 | MM1115 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_DN | 5.31e-10 | 186 | 42 | 8 | MM498 | |
| Coexpression | GOLDRATH_ANTIGEN_RESPONSE | 5.42e-10 | 397 | 42 | 10 | MM1255 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 8.04e-10 | 196 | 42 | 8 | MM3746 | |
| Coexpression | NADLER_OBESITY_UP | 1.08e-09 | 67 | 42 | 6 | MM1007 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 1.11e-09 | 125 | 42 | 7 | MM1065 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_MACROPHAGE_AGEING | 1.31e-09 | 128 | 42 | 7 | MM3838 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN | 1.42e-09 | 70 | 42 | 6 | MM994 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 1.50e-09 | 212 | 42 | 8 | MM3816 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 1.55e-09 | 131 | 42 | 7 | MM1127 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP | 2.23e-09 | 138 | 42 | 7 | MM1047 | |
| Coexpression | DARWICHE_SKIN_TUMOR_PROMOTER_DN | 2.39e-09 | 225 | 42 | 8 | MM496 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | 3.04e-09 | 232 | 42 | 8 | MM1019 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_DN | 5.35e-09 | 87 | 42 | 6 | MM992 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_ACINAR_CELLS | 6.57e-09 | 90 | 42 | 6 | M40267 | |
| Coexpression | BUSSLINGER_DUODENAL_BCHE_CELLS | 7.60e-09 | 43 | 42 | 5 | M40032 | |
| Coexpression | GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN | 8.02e-09 | 93 | 42 | 6 | MM1149 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 9.13e-09 | 267 | 42 | 8 | MM1091 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | 9.28e-09 | 534 | 42 | 10 | MM1050 | |
| Coexpression | TABULA_MURIS_SENIS_DIAPHRAGM_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 9.96e-09 | 270 | 42 | 8 | MM3696 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 1.03e-08 | 97 | 42 | 6 | MM3789 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_HIGH_UP | 1.16e-08 | 175 | 42 | 7 | MM499 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP | 1.16e-08 | 175 | 42 | 7 | MM501 | |
| Coexpression | NEMETH_INFLAMMATORY_RESPONSE_LPS_UP | 1.17e-08 | 99 | 42 | 6 | MM1152 | |
| Coexpression | CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP | 1.40e-08 | 102 | 42 | 6 | M12300 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP | 2.09e-08 | 297 | 42 | 8 | MM1003 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | 2.46e-08 | 112 | 42 | 6 | MM1095 | |
| Coexpression | SUNG_METASTASIS_STROMA_DN | 2.46e-08 | 54 | 42 | 5 | M2904 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP | 2.72e-08 | 198 | 42 | 7 | M5846 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN | 2.82e-08 | 199 | 42 | 7 | M9920 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP | 2.92e-08 | 200 | 42 | 7 | M9909 | |
| Coexpression | LE_EGR2_TARGETS_DN | 3.20e-08 | 117 | 42 | 6 | MM1139 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_B_CELL_AGEING | 3.29e-08 | 315 | 42 | 8 | MM3784 | |
| Coexpression | FOSTER_KDM1A_TARGETS_UP | 3.46e-08 | 317 | 42 | 8 | MM956 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_22 | 4.21e-08 | 211 | 42 | 7 | MM17089 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 4.40e-08 | 327 | 42 | 8 | MM3714 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_DISTAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 4.53e-08 | 124 | 42 | 6 | MM3726 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_BLADDER_CELL_AGEING | 4.94e-08 | 332 | 42 | 8 | MM3679 | |
| Coexpression | NAKAMURA_ADIPOGENESIS_EARLY_UP | 5.42e-08 | 63 | 42 | 5 | M2024 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_FIBROBLAST_OF_LUNG_AGEING | 6.34e-08 | 224 | 42 | 7 | MM3767 | |
| Coexpression | BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP | 7.03e-08 | 25 | 42 | 4 | M15908 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ADVENTITIAL_CELL_AGEING | 8.54e-08 | 234 | 42 | 7 | MM3761 | |
| Coexpression | QI_HYPOXIA | 9.34e-08 | 140 | 42 | 6 | MM1290 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 1.11e-07 | 369 | 42 | 8 | MM16610 | |
| Coexpression | ZHANG_UTERUS_C13_EPITHELIAL1_CELL | 1.54e-07 | 385 | 42 | 8 | MM16619 | |
| Coexpression | FAN_EMBRYONIC_CTX_ASTROCYTE_2 | 1.64e-07 | 154 | 42 | 6 | M39034 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_T_CELL_AGEING | 1.65e-07 | 545 | 42 | 9 | MM3785 | |
| Coexpression | TABULA_MURIS_SENIS_DIAPHRAGM_MESENCHYMAL_STEM_CELL_AGEING | 1.94e-07 | 397 | 42 | 8 | MM3695 | |
| Coexpression | PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN | 2.22e-07 | 162 | 42 | 6 | M1459 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 2.31e-07 | 271 | 42 | 7 | MM1075 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_ENDOTHELIAL_CELL_AGEING | 2.87e-07 | 418 | 42 | 8 | MM3681 | |
| Coexpression | RODRIGUES_NTN1_AND_DCC_TARGETS | 2.88e-07 | 35 | 42 | 4 | M3346 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 3.03e-07 | 421 | 42 | 8 | MM985 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_NK_CELL_AGEING | 3.49e-07 | 288 | 42 | 7 | MM3751 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 3.89e-07 | 435 | 42 | 8 | MM1221 | |
| Coexpression | OLSSON_E2F3_TARGETS_DN | 4.50e-07 | 39 | 42 | 4 | M952 | |
| Coexpression | DURAND_STROMA_NS_UP | 6.39e-07 | 194 | 42 | 6 | MM962 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN | 6.39e-07 | 194 | 42 | 6 | M7942 | |
| Coexpression | CHICAS_RB1_TARGETS_LOW_SERUM | 6.44e-07 | 103 | 42 | 5 | M2126 | |
| Coexpression | GHANDHI_DIRECT_IRRADIATION_UP | 7.09e-07 | 105 | 42 | 5 | M2591 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_UP | 7.42e-07 | 199 | 42 | 6 | M9915 | |
| Coexpression | GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN | 7.42e-07 | 199 | 42 | 6 | M3093 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 7.42e-07 | 199 | 42 | 6 | M5235 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP | 7.64e-07 | 200 | 42 | 6 | M9900 | |
| Coexpression | GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN | 7.64e-07 | 200 | 42 | 6 | M3279 | |
| Coexpression | SASAKI_TARGETS_OF_TP73_AND_TP63 | 8.33e-07 | 12 | 42 | 3 | M17374 | |
| Coexpression | NAKAJIMA_MAST_CELL | 8.85e-07 | 46 | 42 | 4 | M389 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 9.52e-07 | 490 | 42 | 8 | MM1001 | |
| CoexpressionAtlas | Pluripotent Stem Cells-reprogram_NA_vs_Pluripotent Stem Cells-reprogram_OS-NL-Confounder_removed-fold2.0_adjp0.05 | 1.30e-11 | 78 | 30 | 7 | PCBC_ratio_ESC_vs_iPSC_method-OS-NL_cfr-2X-p05 | |
| CoexpressionAtlas | SC blastocyst_vs_SC fibroblast-Confounder_removed-fold2.0_adjp0.05 | 4.06e-10 | 9 | 30 | 4 | PCBC_ratio_SC blastocyst_vs_SC fibroblast_cfr-2X-p05 | |
| CoexpressionAtlas | Pluripotent Stem Cells-method_NA_vs_Pluripotent Stem Cells-method_lenti Cre-excised-Confounder_removed-fold2.0_adjp0.05 | 8.87e-08 | 7 | 30 | 3 | PCBC_ratio_ESC_vs_iPSC_method-lenti Cre-excised_cfr-2X-p05 | |
| CoexpressionAtlas | Pluripotent Stem Cells-reprogram_NA_vs_Pluripotent Stem Cells-reprogram_OSKM-Confounder_removed-fold2.0_adjp0.05 | 1.42e-07 | 8 | 30 | 3 | PCBC_ratio_ESC_vs_iPSC_method-OSKM_cfr-2X-p05 | |
| CoexpressionAtlas | EB cord blood_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.77e-07 | 181 | 30 | 6 | PCBC_ratio_EB cord blood_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | ECTO amniotic fluid MSC_vs_ECTO blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.89e-07 | 183 | 30 | 6 | PCBC_ratio_ECTO amniotic fluid MSC_vs_ECTO blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_NA_vs_Endoderm Differentiated Cells-method_mRNA-Confounder_removed-fold2.0_adjp0.05 | 4.63e-07 | 45 | 30 | 4 | PCBC_ratio_DE_from-ESC_vs_DE_from-mRNA_cfr-2X-p05 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_NA_vs_Endoderm Differentiated Cells-reprogram_OSKM-L-Confounder_removed-fold2.0_adjp0.05 | 4.63e-07 | 45 | 30 | 4 | PCBC_ratio_DE_from-ESC_vs_DE_from-OSKM-L_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | KRTAP2-3 MT1A MT1E MDFIC KRTAP2-1 MT1M MT2A KRTAP2-2 KRTAP1-5 MT1HL1 | 5.46e-07 | 981 | 30 | 10 | PCBC_ctl_BronchSmoothMuscl_1000 |
| CoexpressionAtlas | SC-LF blastocyst_vs_SC blastocyst-Confounder_removed-fold2.0_adjp0.05 | 9.94e-07 | 393 | 30 | 7 | PCBC_ratio_SC-LF blastocyst_vs_SC blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.68e-06 | 266 | 30 | 6 | Arv_SC-hpx_blastocyst_1000_K2 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.71e-06 | 17 | 30 | 3 | gudmap_kidney_P4_CapMesRenVes_Crym_k2_1000 | |
| CoexpressionAtlas | SC blastocyst_vs_SC amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 6.47e-06 | 26 | 30 | 3 | PCBC_ratio_SC blastocyst_vs_SC amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | SC blastocyst_vs_SC bone marrow-Confounder_removed-fold2.0_adjp0.05 | 1.35e-05 | 33 | 30 | 3 | PCBC_ratio_SC blastocyst_vs_SC bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | Pluripotent Stem Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 1.90e-05 | 406 | 30 | 6 | PCBC_ratio_SC_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.08e-05 | 38 | 30 | 3 | gudmap_kidney_P2_CapMes_Crym_k2_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.37e-05 | 120 | 30 | 4 | Arv_SC-H9hpx_1000_K3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_1000 | 4.97e-05 | 987 | 30 | 8 | PCBC_ctl_SmallAirwayEpithel_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_500 | 5.37e-05 | 489 | 30 | 6 | PCBC_ctl_BronchSmoothMuscl_500 | |
| CoexpressionAtlas | Pluripotent Stem Cells-method_NA_vs_Pluripotent Stem Cells-method_plasmid-Confounder_removed-fold2.0_adjp0.05 | 5.37e-05 | 8 | 30 | 2 | PCBC_ratio_ESC_vs_iPSC_method-plasmid_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2 | 7.85e-05 | 163 | 30 | 4 | Arv_SC-hpx_blastocyst_500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#3 | 1.03e-04 | 175 | 30 | 4 | Arv_SC-H9hpx_500_K3 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.59e-04 | 17 | 30 | 2 | gudmap_kidney_adult_Podocyte_MafB_k3_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_2500_k-means-cluster#2 | 3.06e-04 | 428 | 30 | 5 | Arv_SC-H9hpx_2500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000 | 3.65e-04 | 987 | 30 | 7 | Arv_SC-H9hpx_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | 3.65e-04 | 987 | 30 | 7 | Arv_SC-hpx_blastocyst_1000 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-method_NA_vs_Ectoderm Differentiated Cells-method_plasmid-Confounder_removed-fold2.0_adjp0.05 | 3.98e-04 | 102 | 30 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-plasmid_cfr-2X-p05 | |
| CoexpressionAtlas | Pluripotent Stem Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | 7.48e-04 | 796 | 30 | 6 | PCBC_ratio_SC_vs_MESO-5_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-DefinitiveEndoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | 8.65e-04 | 538 | 30 | 5 | ratio_SC_vs_DE_2500_K4 | |
| CoexpressionAtlas | DE blastocyst_vs_DE UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 8.73e-04 | 307 | 30 | 4 | PCBC_ratio_DE blastocyst_vs_DE UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | adipose tissue | 1.49e-03 | 161 | 30 | 3 | adipose tissue | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | KRTAP9-7 KRTAP5-1 KRTAP5-4 KRTAP5-9 KRTAP5-3 KRTAP2-3 KRTAP5-10 KRTAP2-1 KRTAP5-6 KRTAP2-2 KRTAP9-6 KRTAP5-8 KRTAP5-5 KRTAP1-4 KRTAP5-7 KRTAP9-1 KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 3.34e-44 | 146 | 43 | 22 | 522c32103c24fc26836bb5b642083904682d9292 |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10|TCGA-Bladder / Sample_Type by Project: Shred V9 | KRTAP9-7 KRTAP2-3 KRTAP2-2 KRTAP1-4 KRTAP1-5 KRTAP1-3 KRTAP9-8 KRTAP17-1 | 4.88e-13 | 129 | 43 | 8 | 6a201c6344a015e5cf2f79ccf397fd7ad66b6768 |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Primitive_erythrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.90e-12 | 179 | 43 | 8 | 3c8046f43da5a02fa4278a7175b9cd8cf95b8e27 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-11 | 197 | 43 | 8 | eb119e048d5ea1be5f427bb9fb60e5e7b6e84d92 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-10 | 171 | 43 | 7 | f21eae4dd2e0a566eff792d19367e96ffb0b74ba | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-10 | 171 | 43 | 7 | d428c2859a1efc284610ca241a6dae9f182309cd | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-10 | 173 | 43 | 7 | 021457c7bdb55de7351e43322d360e8fd7061658 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.33e-10 | 181 | 43 | 7 | 1c04e53f46992a0aea9d3eee985681ec4e71f80d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.33e-10 | 181 | 43 | 7 | 83adf61f44cebe9e75de175c5dc39237fbf9ed24 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.67e-10 | 183 | 43 | 7 | 7eecb8d80e31ca26c2e6ce43bf0f2c71be1643e4 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.64e-10 | 188 | 43 | 7 | e7f58cd67afac441204c29676de2ffa7aaafd988 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.07e-10 | 190 | 43 | 7 | 799351fea7490d4159271d020c43c845ef37c788 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.07e-10 | 190 | 43 | 7 | ab56800abd1d5cbe2351834a1df749ac7db30892 | |
| ToppCell | NS-critical-d_0-4|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.30e-10 | 191 | 43 | 7 | 769942a6a31c13c583dc38e8a762df2f5c06c2fb | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.53e-10 | 192 | 43 | 7 | 1a3d95a9801cc4569b67fa652b2af46c4dedbaef | |
| ToppCell | Macrophages-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 7.02e-10 | 194 | 43 | 7 | cbb1c65ccee58b2892f7d3fa45773099411c6104 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.28e-10 | 195 | 43 | 7 | 1a4a5623fa0318ef388cc228c7060e0586a7acf9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.28e-10 | 195 | 43 | 7 | 9c24ebce2e3e00b8b692c62a22a53b7d59f0eabb | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.55e-10 | 196 | 43 | 7 | 0df0dbe60e6f643912e5ff30c22415a0513f9bf1 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.55e-10 | 196 | 43 | 7 | 153326be031a58b720da4dab57edd8936d513f8e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.55e-10 | 196 | 43 | 7 | b7748618aaf3ace40940be1b6ca2148e941541a2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.82e-10 | 197 | 43 | 7 | a6a27e5809ee2c9b56c7e06c35e4f140f9fa13ad | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1+SPP1+|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 8.10e-10 | 198 | 43 | 7 | aa90326b82e21de37af5642df6a70a8b21af7f04 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_Inf._Macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.10e-10 | 198 | 43 | 7 | ebc064dede536eda7715af0675fd4e657ff4ac5d | |
| ToppCell | COVID-19-kidney-PCT-S3-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.10e-10 | 198 | 43 | 7 | 36a60397f49f5381ae377155b73e1891448846b7 | |
| ToppCell | COVID-19-kidney-PCT-S3-1|kidney / Disease (COVID-19 only), tissue and cell type | 8.39e-10 | 199 | 43 | 7 | 3e6cfc3c0b2edce0d51db9de80e38f724e6c0cb8 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.39e-10 | 199 | 43 | 7 | 8fcb32eee0ec0dd88209e723a6f82f425c73ca40 | |
| ToppCell | background|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.39e-10 | 199 | 43 | 7 | 5a6d0e00bfe1351eea192b54020bedeef78854e9 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.69e-10 | 200 | 43 | 7 | fc77a0c53201c60933d188ea8d4d86bac6325422 | |
| ToppCell | background-Hepatocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.69e-10 | 200 | 43 | 7 | 423cca10df6ae0489a8fe7e7df87e70364dac022 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.69e-10 | 200 | 43 | 7 | 742441800a2d167c19cee4816ff77424ae6675c6 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-09 | 133 | 43 | 6 | f7d0763b5eec2db33044d6850fd57462494038c1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-08 | 169 | 43 | 6 | 1dfaf9a6b433a5ee86a11962af188978c2543278 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-08 | 169 | 43 | 6 | 3e267ec9f884df326315500dfd751b04a3dd91bd | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-08 | 171 | 43 | 6 | f2b31c97bbcc5164fc279ed0362007878887ad5e | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Primitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.78e-08 | 176 | 43 | 6 | 664a7d15563428d0ae156d97aa88415fd0a0506a | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.97e-08 | 179 | 43 | 6 | 17ba1eedb6ebf039d3b11d099351d0ac6363c8d1 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.97e-08 | 179 | 43 | 6 | 7046f0a426e45fe1b41a25721ee1e33f6fc7f9e3 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.97e-08 | 179 | 43 | 6 | 0e22e840f43ca81a7543dcf33ec17a741cdf7f37 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue-2|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.97e-08 | 179 | 43 | 6 | a20bb3ace5be10c5aef330e9268c0ba55f8fee23 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-08 | 180 | 43 | 6 | 7c7c4d64ff99d0710a7d19d8bc29fc9217394db1 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-08 | 180 | 43 | 6 | 8d9be9cfdf98e5888654a28ab12e5e89f201af00 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-08 | 180 | 43 | 6 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-08 | 180 | 43 | 6 | 8ba9bba0c9fecf184a4332ba4585fb2439f68cd3 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-08 | 180 | 43 | 6 | 271ee52ed8f21f78ddf68e52fc88fe582701675e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-08 | 181 | 43 | 6 | bec917f6f56ae252639a5a76024be5df5c70a6d5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-08 | 181 | 43 | 6 | a8d4b2340d99734bf9379b467fb481c598b9b4fb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-08 | 182 | 43 | 6 | e98ca9df33a1a81fc83ecf73d5141a14f2bc985c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-08 | 183 | 43 | 6 | 263937906ddabc798bbe60f0da28ba859a5c72e2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-08 | 184 | 43 | 6 | 2b83c7a808e97abf836f53aa3243543c8f6762fb | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-08 | 184 | 43 | 6 | 936b39377eebea3961d702532779f6cd27953be7 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-08 | 184 | 43 | 6 | 886d2d9bf2fe31207f17e3edc309ef44029924e1 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-08 | 185 | 43 | 6 | c3d1a312569f3d619f7295812741cbf068ec6c1f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-08 | 186 | 43 | 6 | 41e03be964044dae690d566bd078dab3d8045eba | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-08 | 187 | 43 | 6 | 401be371b32066db926de3415bb4ce9465749dc3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-08 | 187 | 43 | 6 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-08 | 187 | 43 | 6 | 1909b65ba23d598e396f77eecae562bb59bf5d5d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-08 | 188 | 43 | 6 | d00f48afed62fc60d3530bb3b80ac0162b0b0ed8 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.63e-08 | 188 | 43 | 6 | 5d6faf45a9c0794b0c30b0a0601c10afbb8aa9ed | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.63e-08 | 188 | 43 | 6 | a0873783f0a2cd852563c05a275dddc72905ced2 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.63e-08 | 188 | 43 | 6 | 29d804232d974a8c0029300345b287005b09bade | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.63e-08 | 188 | 43 | 6 | 1a751452c0f1f34b3c20fad2fb52c378ab2d0207 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.72e-08 | 189 | 43 | 6 | 8478f433495dabe813146a1f6b00098db8ce775a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.81e-08 | 190 | 43 | 6 | ad0d9aed8c9c99551765d14730d70ebef1ea856b | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-08 | 191 | 43 | 6 | 84c3ccc819fb5acec68daab2e6cc65d5d8909cc4 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-08 | 191 | 43 | 6 | 7717cf1d99b4451d7145d91367637895f9a2c1c3 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-08 | 191 | 43 | 6 | 674e7a27b5f736f14f8513e5ef0d56e4e746d989 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.89e-08 | 191 | 43 | 6 | b7713aba839e7a1f548b7b9d8893067bcc6d7ee7 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-08 | 191 | 43 | 6 | dd73173a898e29624acb22dd783339f3e696a213 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-08 | 191 | 43 | 6 | 7065728128e37572b87e6b024374796bd2172e92 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-08 | 192 | 43 | 6 | 9f7e0d610741288d0779bd7c02852c791431e4ea | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-08 | 192 | 43 | 6 | 9946f5d5cab64936ca68d9f4dc9ce6eba85b43ab | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-08 | 192 | 43 | 6 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-08 | 194 | 43 | 6 | 79baee8b35b7707bbeb07c73b5e17b68bcd7bbc2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-08 | 194 | 43 | 6 | f6e348f1f35c526cad6c349f1fdd0bd92d18aa3c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.18e-08 | 194 | 43 | 6 | 07d8e38cbc2c7f0564c14f7c365f345f901b73b2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-08 | 194 | 43 | 6 | ce599ed0dc181aea0584e426636de5098f34ebe6 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.27e-08 | 195 | 43 | 6 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.27e-08 | 195 | 43 | 6 | 09605533aa5947bb2e5a6725c1ce89f79d330bf5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.27e-08 | 195 | 43 | 6 | 7ff04c45a02df01e3816f3c1d43585a93182a730 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.27e-08 | 195 | 43 | 6 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-08 | 196 | 43 | 6 | 3cf73ed99f3efa76b632c16a8b98b6b7758ff63f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-08 | 196 | 43 | 6 | 52a55bc30e48055823e4161f328ff5808a0ac55c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.37e-08 | 196 | 43 | 6 | 19993604ee64ba85e3f53a784fcf1c934e862f61 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.37e-08 | 196 | 43 | 6 | 79bc7ab96b52b2a542348a13ddd0a4f095698c5e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.48e-08 | 197 | 43 | 6 | 755a53d4206354583bc5b76b63a0b1c9892b7382 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-08 | 197 | 43 | 6 | 291458becbf90e9dda22ea069df7f9a45d827bcd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-08 | 198 | 43 | 6 | 7db113a6e7962ff26c1e1a43baa1a4230cf5f393 | |
| ToppCell | medial|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.58e-08 | 198 | 43 | 6 | 071658de0c43f302172692aa0b4b507dbad7be50 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-08 | 198 | 43 | 6 | 64d73804902a043bdf66b413b769e853d111c033 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-08 | 198 | 43 | 6 | be305d89d48c67ce922fa71aaf15e24d00c89ff6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-08 | 198 | 43 | 6 | 8777117249077d4964dd7566aebde7c443475c7e | |
| ToppCell | 5'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.69e-08 | 199 | 43 | 6 | a5fffe381be1ba7d192b68d1d3937ce47663658e | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.69e-08 | 199 | 43 | 6 | fd1a9f9ab5eeb8c50005304715bb0f35b7926935 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.69e-08 | 199 | 43 | 6 | e09bd3153dd60d06584707b259c78375b47415c8 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.69e-08 | 199 | 43 | 6 | ab71b312635a2b2c98d71b60a299f44bc80a3587 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive-Alveolar_macrophage_MT-positive_L.1.0.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.69e-08 | 199 | 43 | 6 | 8efa724d47b95194d42907ffae17284c3953605e | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.80e-08 | 200 | 43 | 6 | 63a5ae71cfc2aa878a0cea58bdf99da7534b3551 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-HMOX1+_primitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.75e-07 | 161 | 43 | 5 | 6079de6cc4f2aec4091d0fac531fda9a441a70b1 | |
| ToppCell | lung-Club_Cells|lung / shred on tissue and cell subclass | 5.21e-07 | 164 | 43 | 5 | b12cacd499b18b96120ca6d14646aebeaed41d10 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.24e-11 | 50 | 13 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_39_METAL_RESPONSE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.22e-09 | 50 | 13 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_METAL_RESPONSE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.87e-07 | 50 | 13 | 4 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.87e-07 | 50 | 13 | 4 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_7 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.62e-05 | 50 | 13 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_5 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.62e-05 | 50 | 13 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.62e-05 | 50 | 13 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.62e-05 | 50 | 13 | 3 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_MES_GLYCOLYSIS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.60e-03 | 50 | 13 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_HYPOXIA | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.60e-03 | 50 | 13 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_25_ASTROCYTES | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.60e-03 | 50 | 13 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_METAPROGRAM_6_HYPOXIA | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.60e-03 | 50 | 13 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_18_INTERFERON_MHC_II_2 | |
| Computational | B-cell malignancies expression clusters. | 2.69e-03 | 65 | 13 | 2 | MODULE_291 | |
| Computational | Genes in the cancer module 241. | 3.38e-03 | 73 | 13 | 2 | MODULE_241 | |
| Computational | Genes in the cancer module 174. | 5.66e-03 | 95 | 13 | 2 | MODULE_174 | |
| Drug | MeOBGDTC | 9.74e-18 | 11 | 40 | 7 | CID000119173 | |
| Drug | alpha-mercapto-beta-(2-furyl)acrylic acid | 5.05e-17 | 13 | 40 | 7 | CID006437871 | |
| Drug | diamsar | 1.01e-16 | 14 | 40 | 7 | CID000146286 | |
| Drug | Cadmium-thionein | 1.01e-16 | 14 | 40 | 7 | CID000198548 | |
| Drug | MT45 | 1.89e-16 | 15 | 40 | 7 | CID000431865 | |
| Drug | urs-12-ene-3beta,28-diol | 1.89e-16 | 15 | 40 | 7 | CID000092802 | |
| Drug | ZnATP | 5.69e-16 | 17 | 40 | 7 | CID006455240 | |
| Drug | bismuth nitrate | 5.69e-16 | 17 | 40 | 7 | CID000107711 | |
| Drug | azelaic bishydroxamic acid | 5.69e-16 | 17 | 40 | 7 | CID000065268 | |
| Drug | AC1O3QMZ | 1.47e-15 | 19 | 40 | 7 | CID006334573 | |
| Drug | dicarboxymethyldithiocarbamate | 1.66e-15 | 9 | 40 | 6 | CID000130472 | |
| Drug | CAPSO-DTC | 1.66e-15 | 9 | 40 | 6 | CID003081023 | |
| Drug | cadmium oxide | 3.39e-15 | 21 | 40 | 7 | CID000014782 | |
| Drug | 2-(chloromethyl)-4-methoxy-3,5-dimethylpyridine | 4.15e-15 | 10 | 40 | 6 | CID000819992 | |
| Drug | PmMT | 4.15e-15 | 10 | 40 | 6 | CID000085248 | |
| Drug | 4-(2-pyridylazo)resorcinol | 4.96e-15 | 22 | 40 | 7 | CID005370169 | |
| Drug | zinc hydroxide | 4.96e-15 | 22 | 40 | 7 | CID000062742 | |
| Drug | manganese sulfate monohydrate | 7.12e-15 | 23 | 40 | 7 | CID000166832 | |
| Drug | CAP-N-DTC | 9.11e-15 | 11 | 40 | 6 | CID000125337 | |
| Drug | hinokitiol | 1.39e-14 | 25 | 40 | 7 | CID000003611 | |
| Drug | MT20 | 1.90e-14 | 26 | 40 | 7 | CID003025942 | |
| Drug | BGDTC | 1.90e-14 | 26 | 40 | 7 | CID000105107 | |
| Drug | Oral-Turinabol | 2.57e-14 | 27 | 40 | 7 | CID000098521 | |
| Drug | Ormaplatino | 7.56e-14 | 31 | 40 | 7 | CID006434704 | |
| Drug | alpha-hederin | 9.67e-14 | 32 | 40 | 7 | CID000073296 | |
| Drug | Zinquin | 1.23e-13 | 33 | 40 | 7 | CID000132933 | |
| Drug | rhodanine | 1.54e-13 | 34 | 40 | 7 | CID001201546 | |
| Drug | p-hydroxyphenyllactic acid | 2.39e-13 | 36 | 40 | 7 | CID000009378 | |
| Drug | genistin | 3.60e-13 | 38 | 40 | 7 | CID005281377 | |
| Drug | arsenic(III | 5.30e-13 | 40 | 40 | 7 | CID000104734 | |
| Drug | bismuth | 7.65e-13 | 42 | 40 | 7 | CID000105143 | |
| Drug | 4-(2-pyridylazo)resorcinol | 1.06e-12 | 21 | 40 | 6 | CID000104300 | |
| Drug | trans-DDP | 1.08e-12 | 44 | 40 | 7 | CID000084691 | |
| Drug | AC1L45V9 | 1.28e-12 | 45 | 40 | 7 | CID000151205 | |
| Drug | trien | 1.51e-12 | 46 | 40 | 7 | CID000005565 | |
| Drug | midodrine | 1.77e-12 | 47 | 40 | 7 | CID000004195 | |
| Drug | octachloronaphthalene | 1.77e-12 | 47 | 40 | 7 | CID000016692 | |
| Drug | iproplatin | 1.96e-12 | 23 | 40 | 6 | CID003034746 | |
| Drug | dimercaprol | 2.07e-12 | 48 | 40 | 7 | CID000003080 | |
| Drug | DL-propargylglycine | 2.07e-12 | 48 | 40 | 7 | CID000095575 | |
| Drug | dimethylmercury | 3.75e-12 | 52 | 40 | 7 | CID000011645 | |
| Drug | oleanolic acid | 3.75e-12 | 52 | 40 | 7 | CID000010494 | |
| Drug | auranofin | 3.75e-12 | 52 | 40 | 7 | CID006918453 | |
| Drug | Zinc chromate hydroxide | 9.16e-12 | 29 | 40 | 6 | CID000027567 | |
| Drug | tetrathiomolybdate | 1.21e-11 | 61 | 40 | 7 | CID005245480 | |
| Drug | Disperse Blue 7 | 1.21e-11 | 61 | 40 | 7 | CID000018514 | |
| Drug | ZnSO4.7H2O | 1.53e-11 | 63 | 40 | 7 | CID000062639 | |
| Drug | zinc acetate dihydrate | 2.12e-11 | 33 | 40 | 6 | CID000636168 | |
| Drug | DEDTC | 2.58e-11 | 34 | 40 | 6 | CID000032064 | |
| Drug | L-beta-aspartyl phosphate | 2.96e-11 | 69 | 40 | 7 | CID000000832 | |
| Drug | zinc sulfate | 2.96e-11 | 69 | 40 | 7 | CID000024424 | |
| Drug | isopropanol | 3.59e-11 | 122 | 40 | 8 | CID000003776 | |
| Drug | Organoselenium Compounds | 3.64e-11 | 71 | 40 | 7 | ctd:D016566 | |
| Drug | fluoroacetic acid | 4.02e-11 | 72 | 40 | 7 | CID000005236 | |
| Drug | ursolic acid | 4.02e-11 | 72 | 40 | 7 | CID000064945 | |
| Drug | methylcyclopentadienyl)manganese tricarbonyl | 4.44e-11 | 37 | 40 | 6 | CID005150494 | |
| Drug | Fe-NTA | 4.44e-11 | 73 | 40 | 7 | CID000027880 | |
| Drug | 6-aminonicotinamide | 6.21e-11 | 39 | 40 | 6 | CID000009500 | |
| Drug | 1q1g | 6.21e-11 | 39 | 40 | 6 | CID000447992 | |
| Drug | cerium | 6.21e-11 | 39 | 40 | 6 | CID000008762 | |
| Drug | tolmetin glucuronide | 7.87e-11 | 17 | 40 | 5 | ctd:C056583 | |
| Drug | selenium | 8.59e-11 | 80 | 40 | 7 | CID006326970 | |
| Drug | zomepirac glucuronide | 1.09e-10 | 18 | 40 | 5 | ctd:C027368 | |
| Drug | acetylbetulinic acid | 1.70e-10 | 88 | 40 | 7 | CID000289984 | |
| Drug | neutral red | 2.02e-10 | 47 | 40 | 6 | CID000011105 | |
| Drug | CuSO4 | 2.33e-10 | 92 | 40 | 7 | CID000024462 | |
| Drug | S-nitrosocysteine | 2.52e-10 | 93 | 40 | 7 | CID003359494 | |
| Drug | CdCl2 | 3.65e-10 | 98 | 40 | 7 | CID000024947 | |
| Drug | rutin | 3.65e-10 | 98 | 40 | 7 | CID005280805 | |
| Drug | TPEN | 4.22e-10 | 100 | 40 | 7 | CID000005519 | |
| Drug | diethyldithiocarbamate | 4.53e-10 | 101 | 40 | 7 | CID000008987 | |
| Drug | p-terphenyl | 5.20e-10 | 103 | 40 | 7 | CID000007115 | |
| Drug | Ridauran | 5.40e-10 | 55 | 40 | 6 | CID006333887 | |
| Drug | bis-N,N-dimethylamino-2-(N-methylpyrrolyl)methyl cyclopentadienyl titanium (IV) | 5.57e-10 | 104 | 40 | 7 | ctd:C551172 | |
| Drug | fluconazole | 6.81e-10 | 107 | 40 | 7 | CID000003365 | |
| Drug | zinc superoxide | 7.27e-10 | 108 | 40 | 7 | CID000014809 | |
| Drug | unsaturated chondroitin disaccharide | 8.36e-10 | 59 | 40 | 6 | CID000439481 | |
| Drug | CH3Hg | 9.27e-10 | 60 | 40 | 6 | CID000007905 | |
| Drug | thiobarbituric acid | 1.36e-09 | 118 | 40 | 7 | CID002723628 | |
| Drug | Silver Nitrate | 1.44e-09 | 119 | 40 | 7 | ctd:D012835 | |
| Drug | NiCl2 | 1.44e-09 | 119 | 40 | 7 | CID000024385 | |
| Drug | azathioprine | 1.53e-09 | 120 | 40 | 7 | CID000002265 | |
| Drug | AC1L1Z2L | 1.82e-09 | 123 | 40 | 7 | CID000012201 | |
| Drug | adenosine 3',5'-cyclic phosphate | KRTAP5-9 MT1A MT1B MT1E MT1F MT1H MT1X MT2A KRTAP5-8 KRTAP5-7 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 2.59e-09 | 907 | 40 | 13 | CID000000274 |
| Drug | sulfur mustard | 2.68e-09 | 130 | 40 | 7 | CID000010461 | |
| Drug | arsenate | 3.49e-09 | 135 | 40 | 7 | CID000000233 | |
| Drug | acrolein | 3.67e-09 | 136 | 40 | 7 | CID000007847 | |
| Drug | DL-penicillamine | 4.28e-09 | 139 | 40 | 7 | CID000004727 | |
| Drug | motexafin gadolinium | 6.03e-09 | 146 | 40 | 7 | ctd:C437683 | |
| Drug | vanadium | 6.94e-09 | 149 | 40 | 7 | CID000023990 | |
| Drug | lead compounds | 7.27e-09 | 150 | 40 | 7 | CID000073212 | |
| Drug | cilostazol | 8.42e-09 | 86 | 40 | 6 | CID000002754 | |
| Drug | methyl red | 8.42e-09 | 86 | 40 | 6 | CID000010303 | |
| Drug | 5,5'-dithiobis(2-nitrobenzoic acid | 9.98e-09 | 157 | 40 | 7 | CID000006254 | |
| Drug | dihydrochloride | 1.09e-08 | 159 | 40 | 7 | CID000070978 | |
| Drug | XK234 | 1.53e-08 | 167 | 40 | 7 | CID000454923 | |
| Drug | silver nanoparticles | 1.88e-08 | 172 | 40 | 7 | CID000023954 | |
| Drug | sarcolysin | 1.88e-08 | 172 | 40 | 7 | CID000004053 | |
| Drug | Arsenites | 1.91e-08 | 17 | 40 | 4 | ctd:D018053 | |
| Drug | 1,1'-azobis(N,N-dimethylformamide | 1.95e-08 | 173 | 40 | 7 | CID000004278 | |
| Disease | retinitis pigmentosa (biomarker_via_orthology) | 2.50e-15 | 13 | 34 | 6 | DOID:10584 (biomarker_via_orthology) | |
| Disease | median neuropathy (biomarker_via_orthology) | 4.38e-15 | 14 | 34 | 6 | DOID:571 (biomarker_via_orthology) | |
| Disease | kidney failure (biomarker_via_orthology) | 3.94e-14 | 19 | 34 | 6 | DOID:1074 (biomarker_via_orthology) | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 5.70e-11 | 58 | 34 | 6 | DOID:10652 (biomarker_via_orthology) | |
| Disease | cathepsin D measurement | 1.99e-09 | 15 | 34 | 4 | EFO_0010611 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.45e-08 | 157 | 34 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 6.84e-07 | 60 | 34 | 4 | EFO_0020690 | |
| Disease | hair shape measurement | 4.44e-04 | 27 | 34 | 2 | EFO_0007824 | |
| Disease | vitamin D measurement, COVID-19 | 1.46e-03 | 49 | 34 | 2 | EFO_0004631, MONDO_0100096 | |
| Disease | gut microbiome measurement, taxonomic microbiome measurement | 2.64e-03 | 66 | 34 | 2 | EFO_0007874, EFO_0007883 | |
| Disease | Liver carcinoma | 2.66e-03 | 507 | 34 | 4 | C2239176 | |
| Disease | brain volume measurement | 4.70e-03 | 595 | 34 | 4 | EFO_0006930 | |
| Disease | alpha fetoprotein measurement | 5.94e-03 | 100 | 34 | 2 | EFO_0010583 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GCCGSSSTSCCCFPR | 51 | Q9UGL9 | |
| CTSCKKSCCSCCPVG | 26 | Q8N339 | |
| KSCCSCCPVGCAKCA | 31 | Q8N339 | |
| CCPVGCAKCAHGCVC | 36 | Q8N339 | |
| CTSCKKSCCSCCPLG | 26 | P0DM35 | |
| KSCCSCCPLGCAKCA | 31 | P0DM35 | |
| SCGICTSEACCCCCG | 191 | Q9P1T7 | |
| GGGCCQPCCCRDPCC | 16 | Q9BYT5 | |
| GGGCCQPCCCRDPCC | 16 | P0C7H8 | |
| CTSCKKSCCSCCPLG | 26 | P80294 | |
| KSCCSCCPLGCAKCA | 31 | P80294 | |
| CCPLGCAKCAQGCIC | 36 | P80294 | |
| SSSCCPSCCESSCCC | 111 | G5E9R7 | |
| GGCGSSCCVPVCCCK | 36 | Q6L8G5 | |
| KGGCGSCGCSQCNCC | 131 | Q6L8G5 | |
| SCGCSQCNCCKPCCC | 136 | Q6L8G5 | |
| QCNCCKPCCCSSGCG | 141 | Q6L8G5 | |
| KPCCCSSGCGSCCQS | 146 | Q6L8G5 | |
| SSGCGSCCQSSCCNP | 151 | Q6L8G5 | |
| CCCVPACSCSSCGSC | 46 | Q6L8G4 | |
| GCGSCGCSQSNCCKP | 76 | Q6L8G4 | |
| NCCKPCCSSSGCGSF | 86 | Q6L8G4 | |
| GCGSFCCQSSCSKPC | 96 | Q6L8G4 | |
| TSGTCGSSCCQPSCC | 16 | Q07627 | |
| TSGTCGSSCCQPSCC | 16 | Q8IUG1 | |
| GSSCCQPSCCETSCC | 21 | Q8IUG1 | |
| CQPSCCQTSSCGTGC | 71 | Q8IUG1 | |
| TSGTCGSSCCQPSCC | 6 | P0C5Y4 | |
| GSSCCQPSCCETSCC | 11 | P0C5Y4 | |
| GSSCCQPSCCETSCC | 21 | Q9BYS1 | |
| GGGCCQPCCCRDPCC | 16 | Q9BYU5 | |
| CTSCKKSCCSCCPVG | 26 | P04732 | |
| KSCCSCCPVGCAKCA | 31 | P04732 | |
| CCPVGCAKCAQGCVC | 36 | P04732 | |
| GGGCCQPCCCRDPCC | 16 | Q9BYR9 | |
| CCLCCCCCGGGGSTC | 756 | Q9P2E7 | |
| CTSCKKSCCSCCPVG | 26 | P80297 | |
| KSCCSCCPVGCAKCA | 31 | P80297 | |
| CCPVGCAKCAQGCIC | 36 | P80297 | |
| CTSCKKSCCSCCPVG | 26 | P02795 | |
| KSCCSCCPVGCAKCA | 31 | P02795 | |
| CCPVGCAKCAQGCIC | 36 | P02795 | |
| SCSSEDSCLCCCCCG | 191 | Q99750 | |
| DSCLCCCCCGSGECA | 196 | Q99750 | |
| CCCCGSGECADCDLP | 201 | Q99750 | |
| GGSGSSCCVPVCCCK | 36 | Q6L8H4 | |
| CCCVPACSCSSCGKG | 141 | Q6L8H4 | |
| ACSCSSCGKGGCGSC | 146 | Q6L8H4 | |
| SGCGVPVCCCSCSSC | 206 | Q6L8H4 | |
| PVCCCSCSSCGSCAG | 211 | Q6L8H4 | |
| SKGGCGSSCSQCSCC | 226 | Q6L8H4 | |
| GSSCSQCSCCKPCCC | 231 | Q6L8H4 | |
| QCSCCKPCCCSSGCG | 236 | Q6L8H4 | |
| KPCCCSSGCGSSCCQ | 241 | Q6L8H4 | |
| SSGCGSSCCQSSCCK | 246 | Q6L8H4 | |
| SSCCKPCCSQSSCCV | 256 | Q6L8H4 | |
| GGCGSCGCSQSSCCK | 106 | Q701N4 | |
| CGCSQSSCCKPCCCS | 111 | Q701N4 | |
| SSCCKPCCCSSGCGS | 116 | Q701N4 | |
| PCCCSSGCGSSCCQS | 121 | Q701N4 | |
| SGCGSSCCQSSCCKP | 126 | Q701N4 | |
| CCCVPACSCSSCGSC | 46 | Q6L8H2 | |
| GCGSSCCVPVCCSSS | 86 | Q6L8H2 | |
| CCVPVCCSSSCGSCG | 91 | Q6L8H2 | |
| CGSCGCSQCSCYKPC | 121 | Q6L8H2 | |
| CSQCSCYKPCCCSSG | 126 | Q6L8H2 | |
| CYKPCCCSSGCGSSC | 131 | Q6L8H2 | |
| CCSSGCGSSCCQSSC | 136 | Q6L8H2 | |
| CGSSCCQSSCCKPSC | 141 | Q6L8H2 | |
| SQSSCCKPCCCSSGC | 166 | Q6L8H2 | |
| CKPCCCSSGCGSSCC | 171 | Q6L8H2 | |
| CSSGCGSSCCQSSCC | 176 | Q6L8H2 | |
| GSSCCQSSCCKPCCS | 181 | Q6L8H2 | |
| QSSCCKPCCCSSGCG | 196 | Q6L8H2 | |
| KPCCCSSGCGSSCCQ | 201 | Q6L8H2 | |
| SSGCGSSCCQSSCCK | 206 | Q6L8H2 | |
| GCGGCGSSCCVPICC | 41 | Q6L8H1 | |
| CCVPACSCSSCGSCG | 61 | Q6L8H1 | |
| CGSCGCSQCSCCKPC | 191 | Q6L8H1 | |
| CSQCSCCKPCCCSSG | 196 | Q6L8H1 | |
| CCKPCCCSSGCGSSC | 201 | Q6L8H1 | |
| CCSSGCGSSCCQSSC | 206 | Q6L8H1 | |
| CGSSCCQSSCCKPCC | 211 | Q6L8H1 | |
| CQSSCCKPCCSSSGC | 216 | Q6L8H1 | |
| CKPCCSSSGCGSSCC | 221 | Q6L8H1 | |
| GSSCCQSSCCKPYCC | 231 | Q6L8H1 | |
| QSSCCKPCCSSSGCG | 246 | Q6L8H1 | |
| KPCCSSSGCGSSCCQ | 251 | Q6L8H1 | |
| GGCGSGCCVPVCCCK | 56 | Q701N2 | |
| SYGCSQSSCCKPCCC | 151 | Q701N2 | |
| QSSCCKPCCCSSGCG | 156 | Q701N2 | |
| KPCCCSSGCGSSCCQ | 161 | Q701N2 | |
| SSGCGSSCCQSSCCK | 166 | Q701N2 | |
| SSCCKPCSCFSGCGS | 196 | Q701N2 | |
| PCSCFSGCGSSCCQS | 201 | Q701N2 | |
| CGGCGSSCCVPICCC | 21 | Q6L8G9 | |
| CVPACSCTSCGSCGG | 41 | Q6L8G9 | |
| SCTSCGSCGGSKGCC | 46 | Q6L8G9 | |
| SKGGCGSCGCSQCSC | 76 | Q6L8G9 | |
| GSCGCSQCSCCKPCY | 81 | Q6L8G9 | |
| SQCSCCKPCYCSSGC | 86 | Q6L8G9 | |
| CKPCYCSSGCGSSCC | 91 | Q6L8G9 | |
| CSSGCGSSCCQSSCC | 96 | Q6L8G9 | |
| GSSCCQSSCCKPCCS | 101 | Q6L8G9 | |
| CCCVPACSCSSCGSC | 46 | Q6L8G8 | |
| GCGSCGCSQCSCYKP | 86 | Q6L8G8 | |
| GCSQCSCYKPCCCSS | 91 | Q6L8G8 | |
| SCYKPCCCSSGCGSS | 96 | Q6L8G8 | |
| CCCSSGCGSSCCQSS | 101 | Q6L8G8 | |
| GCGSSCCQSSCCKPC | 106 | Q6L8G8 | |
| CCQSSCCKPCCCSSG | 121 | Q6L8G8 | |
| CCKPCCCSSGCGSSC | 126 | Q6L8G8 | |
| CCSSGCGSSCCQSSC | 131 | Q6L8G8 | |
| CGSSCCQSSCCNPCC | 136 | Q6L8G8 | |
| CGGCGSSCCVPICCC | 21 | O75690 | |
| CVPACSCSSCGSCGG | 41 | O75690 | |
| SKGGCGSCGCSQCSC | 76 | O75690 | |
| GSCGCSQCSCYKPCC | 81 | O75690 | |
| SQCSCYKPCCCSSGC | 86 | O75690 | |
| YKPCCCSSGCGSSCC | 91 | O75690 | |
| CSSGCGSSCCQSSCC | 96 | O75690 | |
| GSSCCQSSCCKPCCS | 101 | O75690 | |
| QSSCCKPCSCSSGCG | 116 | O75690 | |
| KPCSCSSGCGSSCCQ | 121 | O75690 | |
| SSGCGSSCCQSSCCK | 126 | O75690 | |
| SSCCKPCCCSSGCGS | 146 | O75690 | |
| PCCCSSGCGSSCCQS | 151 | O75690 | |
| SGCGSSCCQSSCCKP | 156 | O75690 | |
| CCCVPACSCSSCGKR | 46 | P26371 | |
| ACSCSSCGKRGCGSC | 51 | P26371 | |
| GCGSCGCSQCSCCKP | 71 | P26371 | |
| GCSQCSCCKPCCCSS | 76 | P26371 | |
| SCCKPCCCSSGCGSS | 81 | P26371 | |
| CCCSSGCGSSCCQCS | 86 | P26371 | |
| GCGSSCCQCSCCKPY | 91 | P26371 | |
| CSQCSCCKPCCSSSG | 106 | P26371 | |
| CCKPCCSSSGRGSSC | 111 | P26371 | |
| RGSSCCQSSCCKPCC | 121 | P26371 | |
| CQSSCCKPCCSSSGC | 126 | P26371 | |
| CKPCCSSSGCGSSCC | 131 | P26371 | |
| GSSCCQSSCCKPCCS | 141 | P26371 | |
| CQPTCCGSSCCGQTS | 86 | A8MXZ3 | |
| CGSSCCGQTSCGSSC | 91 | A8MXZ3 | |
| CGSSCCQPICGSSCC | 101 | A8MXZ3 | |
| CQPTCGGSSCCSQTC | 191 | A8MXZ3 | |
| CQPTCCGSSCCGQTS | 86 | Q9BYQ4 | |
| CGSSCCGQTSCGSSC | 91 | Q9BYQ4 | |
| CGSSCCGQTSCGSSC | 91 | A8MVA2 | |
| CGSSCCGQTSCGSSC | 86 | A8MTY7 | |
| CQPTCCGQTSCGSSC | 76 | Q9BYQ0 | |
| ECCCQPGCCGCCGSC | 21 | Q9BYP8 | |
| SCCGSSCCGSGCGGC | 51 | Q9BYP8 | |
| CGGGCCGSSCCGSSC | 71 | Q9BYP8 | |
| CGSSCCGSSCCGSGC | 76 | Q9BYP8 | |
| CGSSCCGSGCCGPVC | 81 | Q9BYP8 | |
| CTSCKKSCCSCCPVG | 26 | P04733 | |
| KSCCSCCPVGCSKCA | 31 | P04733 | |
| CCPVGCSKCAQGCVC | 36 | P04733 | |
| CCPMSCAKCAQGCIC | 36 | P04731 | |
| CCPVGCAKCAQGCVC | 36 | P07438 | |
| GTGSGASCCPCCCCC | 161 | Q9BXQ6 | |
| RTCSSCGCGCGKGCC | 66 | P0DSO2 | |
| CRSCGCGCRKGCCQQ | 76 | A0A286YF60 | |
| CGCRKGCCQQKCCCQ | 81 | A0A286YF60 | |
| ACCCGSAGCSLCCDC | 11 | Q86VE9 | |
| PDGGGCSRCCCCCAG | 56 | Q5GH76 | |
| CSRCCCCCAGSGGSA | 61 | Q5GH76 | |
| CCSCGCGCGKGCCQQ | 61 | A0A286YF46 | |
| CLCSGASCLLCSCCP | 16 | Q13530 | |
| GCSCGCGSSGCCCLG | 216 | Q5T750 | |
| CGCGKGCCQQKCCCQ | 101 | A0A286YFB4 | |
| CPCCRGCCGGCCSTP | 41 | A0A286YEY9 | |
| GCCGGCCSTPVICCC | 46 | A0A286YEY9 |